Table 5.
Comp. No | Bax | Bcl-2 | ||
---|---|---|---|---|
Conc (pg/mL) | Fold Change | Conc (ng/mL) | Fold Reduction | |
4a | 298.60 | 36 | 1.05 | 5 |
4b | 284.50 | 34 | 1.17 | 4 |
Doxorubicin | 276.20 | 33 | 1.98 | 2.5 |
Control | 8.30 | 1 | 5.10 | 1 |
Comp. No | Bax | Bcl-2 | ||
---|---|---|---|---|
Conc (pg/mL) | Fold Change | Conc (ng/mL) | Fold Reduction | |
4a | 298.60 | 36 | 1.05 | 5 |
4b | 284.50 | 34 | 1.17 | 4 |
Doxorubicin | 276.20 | 33 | 1.98 | 2.5 |
Control | 8.30 | 1 | 5.10 | 1 |